CAS: 219694-63-0 - Ingavirin
- Synonyms:
- 5-[2-(1H-imidazol-5-yl)ethylamino]-5-oxopentanoic acid
- 5-((2-(1H-imidazol-5-yl)ethyl)amino)-5-oxopentanoic acid
![4-{[2-(1H-imidazol-5-yl)ethyl]carbamoyl}butanoic acid](https://static.cymitquimica.com/products/IN/thumb/DA01BXR0.jpg)
4-{[2-(1H-imidazol-5-yl)ethyl]carbamoyl}butanoic acid
CAS:219694-63-0
Formula:
C10H15N3O3
Purity:
95%
Color and Shape:
Solid
Molecular weight:
225.2444
Ref: IN-DA01BXR0
| 1g | 272.00 € | ||
| 100mg | 102.00 € | ||
| 250mg | 144.00 € |
Estimated delivery in United States, on Wednesday 4 Dec 2024
Ingavirin-d6
CAS:219694-63-0
Formula:
C10H9D6N3O3
Color and Shape:
White To Off-White Solid
Molecular weight:
231.28
Ref: 4Z-I-075002
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Thursday 5 Dec 2024
Ingavirin
CAS:219694-63-0
Formula:
C10H15N3O3
Color and Shape:
White To Off-White Solid
Molecular weight:
225.25
Ref: 4Z-I-075001
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Thursday 5 Dec 2024
![4-{[2-(1H-Imidazol-5-yl)ethyl]carbamoyl}butanoic acid](https://static.cymitquimica.com/products/3D/thumb/UIA69463.jpg)
4-{[2-(1H-Imidazol-5-yl)ethyl]carbamoyl}butanoic acid
CAS:219694-63-0
4-{[2-(1H-Imidazol-5-yl)ethyl]carbamoyl}butanoic acid (4AICB) is a potent replication inhibitor of the influenza virus. It targets the …
Formula:
C10H15N3O3
Purity:
Min. 95%
Color and Shape:
Powder
Molecular weight:
225.24 g/mol
Ref: 3D-UIA69463
| 1g | 888.00 € | ||
| 5g | 2,303.00 € |
Estimated delivery in United States, on Wednesday 15 Jan 2025
Ingavirin
CAS:219694-63-0
Ingavirin, a novel inhibitor of the influenza virus reproduction, inhubits the formation of the virus …
Formula:
C10H15N3O3
Purity:
98%
Color and Shape:
Solid
Molecular weight:
225.24
Ref: TM-T27610
| 25mg | 1,410.00 € | ||
| 50mg | 1,851.00 € | ||
| 100mg | 2,337.00 € |
Estimated delivery in United States, on Wednesday 22 Jan 2025
